Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

Registered drugNo placebo

Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Fludarabine
Sponsor:Technische Universitat Dresden

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Rostock

What the registry says about research in the country

01 Neurodegenerative Diseases

Innovative clinical trials focusing on Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS), investigating new diagnostic tools and therapeutic approaches for early-stage treatment and disease management.

Early-stage Alzheimer's treatment evaluation
ALS therapy with genetic mutations focus
Novel diagnostic imaging techniques

Research includes testing of new compounds and diagnostic methods for improved patient outcomes.

02 Oncology Research

Comprehensive studies in various cancer types, including acute myeloid leukemia, breast cancer, and prostate cancer, exploring innovative treatment combinations and targeted therapies.

Advanced treatment protocols for leukemia
Hormone therapy for breast cancer
Targeted prostate cancer treatments

Focus on personalized medicine approaches and combination therapies for better treatment outcomes.

03 Chronic Conditions

Studies addressing chronic kidney disease, hypertriglyceridemia, and chronic venous ulcers, investigating novel therapeutic approaches and treatment combinations.

Innovative stem cell therapies
Combined treatment approaches
Long-term disease management

Research aimed at improving quality of life and treatment outcomes for patients with chronic conditions.

Back to Germany All countries

Clinical trials in Rostock – page 5

193 trials in Rostock

Cardiac failure acute

Study of empagliflozin compared to placebo in patients with acute decompensated heart failure who are already taking SGLT2 inhibitors

COVID-19

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Neovascular age-related macular degeneration+1

Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

Hepatitis D

Clinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments

Head and neck cancer

Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

COVID-19

Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

Neovascular age-related macular degeneration

Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

Squamous cell carcinoma of the oral cavity+3

Study on Pembrolizumab and Drug Combination for Patients with Recurrent Head and Neck Cancer

Acute myeloid leukaemia

Study of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia

Acute myeloid leukaemia+2

Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

Chronic lymphocytic leukaemia+1

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Acute myeloid leukaemia+1

Study Comparing Treosulfan and Melphalan with Fludarabine for Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Undergoing Transplantation

Filter the trials

Other cities in Germany

Clinical research in Rostock

Prefer not to search? Our Concierge searches the trials for you.